We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Rapid Medical Diagnostic Kits Market to Top USD 23 Billion by 2031 due to Successive Outbreaks of Novel Contagious Viruses

By LabMedica International staff writers
Posted on 01 Nov 2021
Print article

The global rapid medical diagnostic kits market is projected to grow at a CAGR of 4% over the forecast period 2021-2031 to surpass USD 23.1 billion in 2031, driven by the rising prevalence of infectious diseases such as influenza, COVID-19, and others.

Surging application of rapid medical diagnostic kits in substance abuse testing, homecare settings, fertility & pregnancy testing, and veterinary settings is anticipated to further facilitate the market growth over the assessment period. These are the latest findings of Fact.MR (Rockville, MD, USA), a market research and competitive intelligence provider.

In response to the rising prevalence of infectious diseases, the demand for effective testing devices with faster turnaround time has increased. This is expected to create growth opportunities for the market over the coming years. The market is expected to gain traction as an increasing number companies are focusing on receiving approvals to commercially launch their products. The blood glucose testing application is expected to create new growth frontiers for the rapid medical diagnostic kits market through 2031. The blood glucose testing segment is projected to grow by 2x through 2031. Growing diabetic population and rising demand for self-testing devices for monitoring glucose levels at home are key the factors driving the segment’s growth.

Based on test, infectious disease testing is expected to remain a highly remunerative segment, accounting for more than 40% of the total sales by 2031 end. In terms of application, homecare settings is projected to hold contribute 30% of the total revenues by 2021 end. Additionally, the burgeoning adoption of diagnostics kits for testing pregnancies and rising awareness regarding unwanted pregnancies is spurring the sales of rapid medical diagnostic kits across the fertility & pregnancy testing segment. Moreover, increasing research and development activities for developing novel therapeutics for the treatment of various infectious diseases across the US, China, Japan, and India is expected to propel the demand for rapid medical diagnostic kits.

Geographically, the US is anticipated to remain the dominant market for rapid medical diagnostic kits in North America, accounting for nearly 30% of overall sales over the assessment period. China is estimated to witness the fastest growth in the global rapid medical diagnostic kits market, expanding at a CAGR of 7% between 2021 and 2031. Japan is forecasted to account for a substantial revenue share of the East Asia market for rapid medical diagnostic kits, with a projected sales CAGR of 5% through 2031.

“Successive outbreak of novel contagious viruses such as Hantavirus, Ebola, and others along with mutations in COVID-19 and other pathological genes are expected to increase the demand for point-of-care diagnostic solutions. This is expected to augment the growth in the market,” stated a Fact.MR analyst.

Related Links:

Gold Supplier
COVID-19 Real Time RT-PCR Kit
respiraScreen 1
Gold Supplier
Desktop Urine Analyzer
Silver Supplier
COVID-19 Ag Self Test
OnSite COVID-19 Ag Self Test
SARS-CoV-2 Antigen Test
Actim SARS-CoV-2

Print article


Molecular Diagnostics

view channel
Image: Absence of nuclear immunohistochemical staining of MSH2 protein (A) and presence of MLH1 protein (B) in urothelial cell carcinoma of the urinary bladder of a patient carrying a germline MSH2 mutation. Observe the nuclear staining in stromal cells as an internal control (Photo courtesy of Radboud University Nijmegen Medical Centre)

Simple Urine Test Detects Urothelial Cancers in Lynch Syndrome Patients

Lynch Syndrome (LS) is an inherited genetic disorder that carries a high risk of cancer. LS is caused by mutations affecting MLH1, MSH2, MSH6 or PMS2 genes. More than one in 300 people have LS but most... Read more


view channel
Image: The Gazelle Hb Variant Test for screening, diagnosis and management of sickle cell disease and related hemoglobinopathies at the point of care (Photo courtesy of Hemex Health)

Point-of-Care Device Accurately Rapidly Diagnoses Sickle Cell Disease

Hemoglobinopathies are the most common autosomal hereditary disorders. Approximately 7% of the global population carries hemoglobin gene mutation including structural hemoglobin variants like sickle hemoglobin... Read more


view channel
Image: The IMMULITE 2000 XPi Immunoassay System provides multiple tests on a single, easy-to-use analyzer, including the thyroid-stimulating immunoglobulin assay (Photo courtesy of Siemens Healthcare)

Immunoassays Evaluated for Thyroid-Stimulating Receptor Antibody in Graves’ Disease

Graves' disease (GD), also known as toxic diffuse goiter, is an autoimmune disease that affects the thyroid. It frequently results in and is the most common cause of hyperthyroidism and it also often results... Read more


view channel
Image: The sciREADER CL2 enables high quality digital colorimetric imaging of various support formats (Photo courtesy of SCIENION)

Multiplex Immunoassay Developed for Confirmation and Typing of HTLV Infections

Human T-Cell Lymphotropic Viruses (HTLV) type 1 and type 2 account for an estimated five to 10 million infections worldwide and are transmitted through breast feeding, sexual contacts and contaminated... Read more


view channel

AI Accurately Detects and Diagnoses Colorectal Cancer from Tissue Scans As Well or Better Than Pathologists

Artificial intelligence (A) can accurately detect and diagnose colorectal cancer from tissue scans as well or better than pathologists, according to a new study. The study, which was conducted by researchers... Read more


view channel
Image: PKeye Workflow Monitor System (Photo courtesy of PerkinElmer, Inc.)

PerkinElmer’s New Cloud-Based Platform Enables Laboratory Personnel to Remotely Manage Its Instruments in Real-Time

PerkinElmer, Inc. (Waltham, MA; USA) has launched its PKeye Workflow Monitor, a cloud-based platform enabling laboratory personnel to remotely manage and monitor their PerkinElmer instruments and workflows... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.